Vaccines, Repurposed Drugs and Alternative Biomedicines for the Management and Prevention of COVID-19

• Published in: Journal of clinical and diagnostic research Vol. 15; no. 9; pp. KE01 - KE08
• Main Authors: Kandhavelu, Jeyalakshmi, Veeriah, Ramesh, Subramanian, Kumar, Rajendran, Priyatharsini, Yli-Harja, Olli, Kandhavelu, Meenakshisundaram, Murugesan, Akshaya
• Format: Journal Article
• Language: English
• Published: JCDR Research and Publications Private Limited 01.09.2021
• Subjects: antibody vaccine; coronavirus disease 2019; recombinant vaccine; traditional medicine
• ISSN: 2249-782X; 0973-709X
• DOI: 10.7860/JCDR/2021/49523.15342

The Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) popularly called as COVID-19, is a pandemic having affected >200 countries. Globally, quarantine measures have been implemented to slow down the spread of the virus. Yet, the available vaccines and drugs for treating COVID-19 are still in design and developmental stage, requiring clinical validation. This review is focused on the progress in the development of medicines against SARS-CoV-2. As an alternative approach, both conventional and traditional biomedicines are also reported to be in practice, to treat the SARS-CoV-2 infected patients. Considering the therapeutic values of the folk medicines, this review focuses on the usage of high value added products from plants, against COVID-19 in managing the symptoms like fever, cough, cold, sore throat, respiratory disorders and kidney dysfunctions enlisting a few used since time immemorial. It is ardently hoped that scientific intervention of such traditional plants can be integrated to harmonise with modern medicine, to ensure its dosage and safety in augmenting disease management.